Skip to Main Content

Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say, “Every brand new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and invite you to join us. Remember, a prescription is not required. Our choice today is salted caramel mocha. A taste of the Jersey shore, as we like to say. Meanwhile, here are a few items of interest. Hope you have a smashing day and, of course, do stay in touch. …

Robert Califf spent his first confirmation hearing explaining his entanglements with the pharmaceutical industry to senators as they evaluated his candidacy to helm the U.S. Food and Drug Administration under President Obama. But now, if President Biden nominates him to lead the FDA again, Califf will have to explain his connection to another industry that’s vilified on Capitol Hill: “Big Tech,STAT writes. It is not clear what Califf does day to day as the head of clinical policy and strategy at Verily, the life sciences arm of Google parent company Alphabet (GOOGL). Even one of Califf’s friends had trouble explaining his role.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment